660435-04-1

1H-Benzimidazol-2-amine,1-[(1-methylethyl)sulfonyl]-6-[[(4-nitrophenyl)imino]methyl]-

1H-Benzimidazol-2-amine,1-[(1-methylethyl)sulfonyl]-6-[[(4-nitrophenyl)imino]methyl]-

Catalog No.1536497
Name 1H-Benzimidazol-2-amine,1-[(1-methylethyl)sulfonyl]-6-[[(4-nitrophenyl)imino]methyl]-
CAS660435-04-1
FormulaC17H17N5O4S

Request a Quote

Structure of 660435-04-1

About 1H-Benzimidazol-2-amine,1-[(1-methylethyl)sulfonyl]-6-[[(4-nitrophenyl)imino]methyl]-

1H-Benzimidazol-2-amine,1-[(1-methylethyl)sulfonyl]-6-[[(4-nitrophenyl)imino]methyl]- is a chemical compound registered under CAS number 660435-04-1, with the molecular formula C17H17N5O4S and a molecular weight of about 387.41 g/mol. KingPharm Group supplies 1H-Benzimidazol-2-amine,1-[(1-methylethyl)sulfonyl]-6-[[(4-nitrophenyl)imino]methyl]- for laboratory research and bulk production; product code 1536497. Send an inquiry for purity, packaging, price and lead time.

CAS Number
660435-04-1
Molecular Formula
C17H17N5O4S
Molecular Weight
387.41 g/mol

Related Products

  1. 3-Isoxazolecarboxamide,N-[2-[3-[(4-methyl-1-piperazinyl)methyl]phenoxy]ethyl]-5-phenyl-
    897405-61-7
  2. Cbz-N-methyl-DL-leucine
    117290-40-1
  3. Dimethyl-13C2 disulfide
    1173019-13-0
  4. Pyrrolidine, 3-[(1,4,5,6,7,8-hexahydro-1-naphthalenyl)methyl]-1-methyl-
    58689-44-4
  5. 2-Ethyl-4-phenylpyrimidine-5-carboxylic acid
    1172714-62-3
  6. 1H-Imidazole-4,5-dicarbonitrile, 2-(cyanomethyl)-
    137995-35-8
  7. 3-(1-methyl-1H-pyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
  8. Bromochloroacetic acid-1-13C
  9. Bis(1-(2-bromophenyl)ethyl)amine, HCl
  10. (2E)-4,4,4-Trifluoro-N-methoxy-N-methyl-2-butenamide
  11. 660435-04-1 msds
  12. CAS No 660435-04-1 supplier
  13. CASNo 660435-04-1 distributor
  14. CAS # 660435-04-1 manufacturer
  15. CAS Number 660435-04-1 safety
  16. CAS RN 660435-04-1 wholesale
  17. 2026-11-06 Find 1H-Benzimidazol-2-amine,1-[(1-methylethyl)sulfonyl]-6-[[(4-nitrophenyl)imino]methyl]-,CAS No.660435-04-1,Formula:C17H17N5O4S in KingPharm Group